NAP1L5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.3624218660816E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.14559473018971E-11 |
Normal-vs-Stage2 |
6.89559520594685E-12 |
Normal-vs-Stage3 |
2.51130005679556E-10 |
Normal-vs-Stage4 |
4.01612076927904E-12 |
Stage1-vs-Stage2 |
7.470400E-01 |
Stage1-vs-Stage3 |
8.790000E-01 |
Stage1-vs-Stage4 |
7.972100E-02 |
Stage2-vs-Stage3 |
7.128600E-01 |
Stage2-vs-Stage4 |
7.974500E-02 |
Stage3-vs-Stage4 |
1.055450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.03872507554115E-12 |
Normal-vs-AfricanAmerican |
1.92329485670939E-11 |
Normal-vs-Asian |
4.580400E-03 |
Caucasian-vs-AfricanAmerican |
9.208300E-02 |
Caucasian-vs-Asian |
2.143000E-01 |
AfricanAmerican-vs-Asian |
1.261830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.9578119387661E-12 |
Normal-vs-Female |
2.30410135415582E-11 |
Male-vs-Female |
7.987900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.63817872997652E-12 |
Normal-vs-Extreme_Weight |
2.63244981368871E-12 |
Normal-vs-Obese |
1.15609744000267E-11 |
Normal-vs-Extreme_Obese |
1.18000000004503E-06 |
Normal_Weight-vs-Extreme_Weight |
6.828600E-01 |
Normal_Weight-vs-Obese |
8.819400E-01 |
Normal_Weight-vs-Extreme_Obese |
8.618600E-01 |
Extreme_Weight-vs-Obese |
4.660000E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.689000E-01 |
Obese-vs-Extreme_Obese |
9.203000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.77420000305284E-08 |
Normal-vs-Age(41-60Yrs) |
8.01803068384288E-12 |
Normal-vs-Age(61-80Yrs) |
5.74185143875638E-12 |
Normal-vs-Age(81-100Yrs) |
4.02400002208481E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.950600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.906800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.087600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.697000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.720600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.047000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.00601773975495E-12 |
Normal-VS-Type2 PRCC |
6.25950402621811E-11 |
Normal-VS-KIRP CIMP |
1.90958360235527E-14 |
Normal-VS-Unclassified PRCC |
1.05270236971933E-11 |
Type1 PRCC-VS-Type2 PRCC |
6.611000E-04 |
Type1 PRCC-VS-KIRP CIMP |
3.8442000027672E-08 |
Type1 PRCC-VS-Unclassified PRCC |
2.174100E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.85980120193108E-11 |
Type2 PRCC-VS-Unclassified PRCC |
2.627800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.61159999579175E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.38433708940511E-12 |
Normal-vs-N1 |
1.04749997564824E-09 |
Normal-vs-N2 |
7.169900E-04 |
N0-vs-N1 |
6.101000E-01 |
N0-vs-N2 |
8.328400E-01 |
N1-vs-N2 |
7.270000E-01 |
|
|